tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ami Fadia, 322 are a BUY (85.64%), 50 are a HOLD (13.3%), 4 are a SELL (1.06%).
Analyst Ami Fadia, carries an average stock price target met ratio of 41.64% that have a potential upside of 34.31% achieved within 174 days. Previously, Ami Fadia worked at LEERINK.
Ami Fadia’s has documented 702 price targets and ratings displayed on 35 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 23-Sep-2025.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 10/12/2023. The price target of $34 was fulfilled within 4 days with a profit of $9.8 (40.5%) receiving and performance score of 101.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$12
$-6.84 (-36.31%)
$7
3 months 14 days ago
(24-Jun-2025)
8/13 (61.54%)
$-4.19 (-25.88%)
55
Buy
1 years 3 months 21 days ago
(17-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
1 years 10 months 19 days ago
(19-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$1.16 (6.16%)
$60
1 years 11 months 14 days ago
(24-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$6.16 (32.70%)
$40
2 years 2 months 20 days ago
(18-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Ami Fadia is most bullish on?
Which stock is Ami Fadia is most reserved on?
What Year was the first public recommendation made by Ami Fadia?
